Organigram Global Inc.
Every calculator, already run for OGI
Open the full toolkit →You have the numbers on OGI. Get the argument.
A written report on which of these readings actually decide the outcome for Organigram Global Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
5 analysts covering OGIOwnership & short interest
Insider Trading Activity for OGI
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Organigram Global Inc.
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes,…
OGI — frequently asked
Is OGI a buy right now?
Wall Street's consensus rating on Organigram Global Inc. is Buy across 5 analysts. Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is OGI overvalued?
OGI trades at 2.4x trailing earnings. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
Compare Organigram Global Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Organigram Global Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full OGI research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Organigram Global Inc., in minutes. 3 free reports included with every account — no credit card required.